Urinary excretion of podocytes in patients with diabetic nephropathy.

No abstract is available for this paper.

• Publication year

  2000

• Venue

  Nephrology, Dialysis and Transplantation

• Publication date

  2000-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1093/NDT/15.9.1379PMID 10978394
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ACE inhibitors and diabetic nephropathy: clinical and experimental findings

  2004cited by this paper
• Elevation of Serum Levels of Metalloproteinase-1, Tissue Inhibitor of Metalloproteinase-1 and Type IV Collagen, and Plasma Levels of Metalloproteinase-9 in Polycystic Kidney Disease

  2000cited by this paper
• Podocyte number predicts long-term urinary albumin excretion in Pima Indians with Type II diabetes and microalbuminuria

  1999cited by this paper
• Increased plasma metalloproteinase-9 concentrations precede development of microalbuminuria in non-insulin-dependent diabetes mellitus.

  1998influential reference
• Microalbuminuria in essential hypertension.

  1998cited by this paper
• Immunohistochemical and urinary markers of podocyte injury

  1998cited by this paper
• Urinary Excretion of Podocytes Reflects Disease Activity in Children with Glomerulonephritis

  1998cited by this paper
• Effect of cigarette smoking on plasma metalloproteinase-9 concentration.

  1998cited by this paper
• Effects of an ACE inhibitor/calcium antagonist combination on proteinuria in diabetic nephropathy.

  1998cited by this paper
• Alterations in the expression of the a3b1 integrin in certain membrane domains of the glomerular epithelial cells (podocytes) in diabetes mellitus

  1997cited by this paper
• Podocyte loss and progressive glomerular injury in type II diabetes.

  1997cited by this paper
• Effective Postponement of Diabetic Nephropathy With Enalapril in Normotensive Type 2 Diabetic Patients With Microalbuminuria

  1997cited by this paper
• Predictors of the progression of diabetic nephropathy and the beneficial effect of angiotensin-converting enzyme inhibitors in NIDDM patients

  1997cited by this paper
• Characterization of a glomerular epithelial cell metalloproteinase as matrix metalloproteinase-9 with enhanced expression in a model of membranous nephropathy.

  1996cited by this paper
• Long-term renoprotective effect of angiotensin-converting enzyme inhibition in non-insulin-dependent diabetes mellitus. A 7-year follow-up study.

  1996cited by this paper
• Urinary excretion of podocalyxin indicates glomerular epithelial cell injuries in glomerulonephritis.

  1995influential reference
• Morphometric detection of incipient glomerular lesions in diabetic nephropathy in rats. Protective effects of ACE inhibition.

  1995cited by this paper
• Endothelial Dysfunction Precedes Development of Microalbuminuria in IDDM

  1995cited by this paper
• Long‐Term Therapy with Trandolapril, a New Nonsulfhydryl ACE Inhibitor, in Hypertension: A Multicenter International Trial

  1994cited by this paper
• A one-step sandwich enzyme immunoassay for inactive precursor and complexed forms of human matrix metalloproteinase 9 (92 kDa gelatinase/type IV collagenase, gelatinase B) using monoclonal antibodies.

  1994cited by this paper
• Long-term therapy with trandolapril, a new nonsulfhydryl ACE inhibitor, in hypertension: a multicenter international trial. Investigator Study Group.

  1994cited by this paper
• The role of the glomerular epithelial cell in the maintenance of the glomerular filtration barrier.

  1993cited by this paper
• Human 92- and 72-kilodalton type IV collagenases are elastases.

  1991cited by this paper
• Identification of a major sialoprotein in the glycocalyx of human visceral glomerular epithelial cells.

  1986cited by this paper
• Monoclonal antibodies to human glomerular cells: a marker for glomerular epithelial cells.

  1983cited by this paper

• Diagnostic performance of urinary podocyte biomarkers and TGF-β/Smad signaling markers in diabetic nephropathy

  2026cites this paper
• Utility of urinary podocalyxin levels in patients with and without type 2 diabetic nephropathy and its correlation with renal function.

  2026cites this paper
• Preservation of Urinary Podocyte Markers in Diabetic Kidney Disease by Sodium-Glucose Cotransporter 2 Inhibitor Therapy

  2025cites this paper
• The Prognostic Value for Tissue Inhibitor of Metalloproteinase-2 and Fatty Acid-Binding Protein-1 as Biomarkers for Chronic Kidney Disease

  2025cites this paper
• Serum matrix metalloproteinase-9 as a predictor of recurrence in idiopathic nephrotic syndrome

  2025cites this paper
• Insights into diabetic nephropathy biomarkers with focus on existing indices and potential future developments

  2025cites this paper
• rs-TAC PDC, a peptide drug-conjugate, for targeted delivery of tacrolimus and sericin alleviates podocyte injury in diabetic nephropathy

  2024cites this paper
• Diabetes and Renal Complications: An Overview on Pathophysiology, Biomarkers and Therapeutic Interventions

  2024cites this paper
• The Role of Selenium Nanoparticles in Addressing Diabetic Complications: A Comprehensive Study.

  2024cites this paper
• Injectable, reversibly thermoresponsive captopril-laden hydrogel for the local treatment of sensory loss in diabetic neuropathy

  2024cites this paper
• Diabetic Nephropathy and Gaseous Modulators

  2023cites this paper
• Urinary Podocyte Excretion Predicts Urinary Protein Selectivity and Renal Prognosis

  2022cites this paper
• A pilot study of changes in urinary podocalyxin levels during normal pregnancy and labor

  2022cites this paper
• Glucosidase inhibitor, Nimbidiol ameliorates renal fibrosis and dysfunction in type-1 diabetes

  2022cites this paper
• Modes of podocyte death in diabetic kidney disease: an update

  2022cites this paper
• Emerging Biomarkers for Early Detection of Chronic Kidney Disease

  2022cites this paper
• Podocyturia: an earlier biomarker of cardiovascular outcomes

  2022cites this paper
• TFP5-Mediated CDK5 Activity Inhibition Improves Diabetic Nephropathy via NGF/Sirt1 Regulating Axis

  2022cites this paper
• Nephrinuria and podocytopathies.

  2022cites this paper
• Cdc42 upregulation under high glucose induces podocyte apoptosis and impairs β-cell insulin secretion

  2022cites this paper
• Effects of SGLT2 inhibitors on patients with diabetic kidney disease: A preliminary study on the basis of podocyturia

  2022cites this paper
• Enhanced SHP-1 Expression in Podocyturia Is Associated with Kidney Dysfunction in Patients with Diabetes

  2022cites this paper
• Mechanisms of podocyte injury and implications for diabetic nephropathy

  2022cites this paper
• Histological Manifestations of Diabetic Kidney Disease and its Relationship with Insulin Resistance.

  2022cites this paper
• Urinary mRNA Expression of Glomerular Podocyte Markers in Glomerular Disease and Renal Transplant

  2021cites this paper
• Alpha-1 Acid Glycoprotein and Podocin mRNA as Novel Biomarkers for Early Glomerular Injury in Obese Children

  2021cites this paper
• GYY4137 Regulates Extracellular Matrix Turnover in the Diabetic Kidney by Modulating Retinoid X Receptor Signaling

  2021cites this paper
• Peptide Charge Derivatization as a Tool for Early Detection of Preeclampsia by Mass Spectrometry—A Comparison with the ELISA Test

  2021cites this paper
• Beneficial effects of metformin on glomerular podocytes in diabetes.

  2021cites this paper
• Matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases in kidney disease.

  2021cites this paper
• Urine-Derived Epithelial Cells as Models for Genetic Kidney Diseases

  2021cites this paper
• Urinary Single-Cell Profiling Captures the Cellular Diversity of the Kidney.

  2021cites this paper
• A UFLC-MS/MS Method for the Simultaneous Analysis of Urinary Podocin and Podocalyxin in Patients with Nephrotic Syndrome.

  2021cites this paper
• Knowledge Domain and Emerging Trends in Podocyte Injury Research From 1994 to 2021: A Bibliometric and Visualized Analysis

  2021cites this paper
• Diabetic Kidney Disease

  2020cites this paper
• Study of Urinary Podocalyxin As an Early Biomarker in Diabetic Nephropathy

  2020cites this paper
• Molecular and functional characterization of urine‐derived podocytes from patients with Alport syndrome

  2020cites this paper
• Experimental Animal Models of Diabetic Kidney Disease

  2020cites this paper
• Role of urinary podocalyxin in early diagnosis of diabetic nephropathy

  2020cites this paper
• Diabetic kidney disease: seven questions

  2020cites this paper
• From Infancy to Fancy: A Glimpse into the Evolutionary Journey of Podocytes in Culture.

  2020cites this paper
• Microvascular Dysfunction in Diabetes Mellitus and Cardiometabolic Disease.

  2020cites this paper
• Mechanism of Albuminuria Reduction by Chymase Inhibition in Diabetic Mice

  2020cites this paper
• Study of The Podocalyxin as An Early Marker for Diabetic Nephropathy and Its Correlation with Stages of Diabetic Nephropathy in A Sample of Egyptian Patients with T2DM

  2020cites this paper
• Changes in the biochemical, hematological and histopathological parameters in STZ-Induced diabetic rats and the ameliorative effect of Kigelia africana fruit extract

  2020cites this paper
• Several reasons for the development of proteinuria in nephrotic syndrome

  2020cites this paper
• The Role of Podocytes and Podocyte-Associated Biomarkers in Diagnosis and Treatment of Diabetic Kidney Disease

  2020cites this paper
• Mitotic Catastrophe Causes Podocyte Loss in the Urine of Human Diabetics.

  2019cites this paper
• A Liquid-Based Cytology System, without the Use of Cytocentrifugation, for Detection of Podocytes in Urine Samples of Patients with Diabetic Nephropathy

  2019cites this paper
• Diabetic nephropathy and type 1 diabetes mellitus: what is new?

  2019cites this paper
• Diabetic Kidney Disease: Past and Present.

  2019cites this paper
• Matrix Metalloproteinases in Renal Diseases: A Critical Appraisal

  2019cites this paper
• Urinary nephrin is earlier, more sensitive and specific marker of diabetic nephropathy than microalbuminuria

  2019cites this paper
• High glucose reduces the expression of podocin in cultured human podocytes by stimulating TRPC6.

  2019cites this paper
• Podocyte Injury in Autosomal Dominant Polycystic Kidney Disease

  2019cites this paper
• Impaired Regeneration Potential in Urinary Stem Cells Diagnosed from the Patients with Diabetic Nephropathy

  2019cites this paper
• High glucose induces podocyte epithelial-to-mesenchymal transition by demethylation-mediated enhancement of MMP9 expression

  2018cites this paper
• Development of a Novel Scaffold of Chitosan, Type IV Collagen and Integrin α3β1 As Alternative Scaffold for Primary Culture of Podocytes

  2018cites this paper
• The correlation of urinary podocytes and podocalyxin with histological features of lupus nephritis

  2018cites this paper
• Urine‐derived podocytes‐lineage cells: A promising tool for precision medicine in Alport Syndrome

  2018cites this paper
• New Insights into the Molecular Mechanisms of Podocytes Injury in Diabetes

  2018cites this paper
• Quantifying Podocytes and Parietal Epithelial Cells in Human Urine Using Liquid-based Cytology and WT1 Immunoenzyme Staining.

  2018cites this paper
• Amelioration of Diabetic Nephropathy Using a Retinoic Acid Receptor β2 Agonist

  2018cites this paper
• Glomerular endothelial cells versus podocytes as the cellular target in diabetic nephropathy

  2018cites this paper
• A causal link between oxidative stress and inflammation in cardiovascular and renal complications of diabetes.

  2018cites this paper
• Podocytes contribute, and respond, to the inflammatory environment in lupus nephritis

  2018cites this paper
• Pathology of the Kidney in Diabetes

  2018cites this paper
• Human glomerular transcriptome of diabetic kidneys: Can the podocyte cytoskeleton be a therapeutic target?

  2018cites this paper
• A novel splicing variant of small nucleolar RNA host gene 4 is a podocyte-selective non-coding RNA upregulated in response to puromycin aminonucleoside-induced podocyte injury.

  2018cites this paper
• PLK2 Plays an Essential Role in High D-Glucose-Induced Apoptosis, ROS Generation and Inflammation in Podocytes

  2017cites this paper
• Podocyte Injury in Diabetic Nephropathy

  2017cites this paper
• Epithelial-mesenchymal Transition of Glomerular Podocytes: Implications in Proteinuria

  2017cites this paper
• Podocyturia parallels proximal tubule dysfunction in type 2 diabetes mellitus patients independently of albuminuria and renal function decline: A cross-sectional study.

  2017cites this paper
• Diabetes-Induced Reactive Oxygen Species: Mechanism of Their Generation and Role in Renal Injury

  2017cites this paper
• MDM2 is implicated in high‐glucose‐induced podocyte mitotic catastrophe via Notch1 signalling

  2017cites this paper
• Novel Actions of Growth Hormone in Podocytes: Implications for Diabetic Nephropathy

  2017influential citation
• In IgA Nephropathy, Glomerulosclerosis Is Associated with Increased Urinary CD80 Excretion and Urokinase-Type Plasminogen Activator Receptor-Positive Podocyturia

  2017cites this paper
• Soluble Urokinase Receptor and the Kidney Response in Diabetes Mellitus

  2017cites this paper
• Urinary WT1‐positive cells as a non‐invasive biomarker of crescent formation

  2017cites this paper
• Urinary podocyte-associated mRNA levels correlate with proximal tubule dysfunction in early diabetic nephropathy of type 2 diabetes mellitus

  2017influential citation
• Regulation of high glucose-induced apoptosis of brain pericytes by mitochondrial CA VA: A specific target for prevention of diabetic cerebrovascular pathology.

  2017cites this paper
• Diabetes Induced Changes in Podocyte Morphology and Gene Expression Evaluated Using GFP Transgenic Podocytes

  2016cites this paper
• Podocyturia is significantly elevated in untreated vs treated Fabry adult patients

  2016cites this paper
• Podocyte Detachment in Type 2 Diabetic Nephropathy

  2016cites this paper
• Silencing of Histone Deacetylase 9 Expression in Podocytes Attenuates Kidney Injury in Diabetic Nephropathy

  2016cites this paper
• Carboxymethyl lysine induces EMT in podocytes through transcription factor ZEB2: Implications for podocyte depletion and proteinuria in diabetes mellitus.

  2016cites this paper
• Regulation of Podocyte apoptosis in Diabetic Kidney Disease - Role of SHIP2, PDK1 and CDK2

  2016cites this paper
• Podocyturia in Fabry disease.

  2016cites this paper
• Nephrin and Podocalyxin - New Podocyte Proteins for Early Detection of Secondary Nephropathies

  2016cites this paper
• Cyclin-dependent kinase 2 protects podocytes from apoptosis

  2016cites this paper
• Podocyturia: A Clue for the Rational Use of Amiloride in Alport Renal Disease

  2016cites this paper
• Silencing of USP22 suppresses high glucose-induced apoptosis, ROS production and inflammation in podocytes.

  2016cites this paper
• WT1 immunoenzyme staining using SurePath™ processed urine cytology helps to detect kidney disease

  2016cites this paper
• Monoclonal Antibody Pharmacokinetics in Type 2 Diabetes Mellitus and Diabetic Nephropathy

  2016cites this paper
• Novel Biomarkers for Renal Diseases? None for the Moment (but One)

  2016cites this paper
• Rethinking glomerular basement membrane thickening in diabetic nephropathy: adaptive or pathogenic?

  2016cites this paper
• Effects of overexpressing FoxO1 on apoptosis in glomeruli of diabetic mice and in podocytes cultured in high glucose medium.

  2016cites this paper
• Advances in Urine Microscopy.

  2016cites this paper
• The Search for Molecular Prognostic Markers of Diabetic Nephropathy in Patients with Type 2 Diabetes Mellitus

  2016cites this paper
• PODOCYTURIA mRNAs: EARLIER AND SUPERIOR PREDICTORS OF CARDIOVASCULAR OUTCOMES

  2016cites this paper